Actinic Keratosis
Real People. Real Results.
Fraxel for Actinic Keratosis
Actinic Keratosis (AK) is a common pre-cancerous skin condition that affects approximately 10 million Americans each year. AK lesions typically appear as a scaly or crusty growth in areas that are frequently exposed to sunlight. People who have fair complexions are more prone to AKs than are people with medium or dark skin.
Although Actinic Keratosis is considered a pre-cancerous condition, it is very treatable. Standard therapies include topical ointments, freezing, surgical excision and Photodynamic Therapy (PDT) . Now physicians are increasingly turning to lasers, such as Fraxel technology, to effectively treat AKs.
FRAXEL BY THE NUMBERS
In science and medicine, sometimes statistics can tell a bigger-picture story. Some impressive numbers:
Some impressive numbers:
-- Fraxel is available in more than 80 countries worldwide
-- Over 2,500 physicians offer Fraxel treatment
-- Over 800,000 procedures performed
-- Over 45 patents have been issued on unique fractional laser technology
-- Thermage received aesthetic clearance in 2003